摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-methylenedioxy-9-O-(4-trifluoromethylbenzenesulfonyl)-10-methoxy-13-n-octylprotoberberine chloride | 1375475-72-1

中文名称
——
中文别名
——
英文名称
2,3-methylenedioxy-9-O-(4-trifluoromethylbenzenesulfonyl)-10-methoxy-13-n-octylprotoberberine chloride
英文别名
(17-Methoxy-21-octyl-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-16-yl) 4-(trifluoromethyl)benzenesulfonate;chloride
2,3-methylenedioxy-9-O-(4-trifluoromethylbenzenesulfonyl)-10-methoxy-13-n-octylprotoberberine chloride化学式
CAS
1375475-72-1
化学式
C34H35F3NO6S*Cl
mdl
——
分子量
678.169
InChiKey
YOZJGXWSHKGZKN-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.78
  • 重原子数:
    46
  • 可旋转键数:
    11
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    83.3
  • 氢给体数:
    0
  • 氢受体数:
    10

反应信息

  • 作为产物:
    描述:
    盐酸小檗碱吡啶 、 sodium tetrahydroborate 、 potassium carbonate溶剂黄146 、 sodium hydroxide 作用下, 以 甲醇乙醇乙腈 为溶剂, 20.0~210.0 ℃ 、5.33 kPa 条件下, 反应 7.5h, 生成 2,3-methylenedioxy-9-O-(4-trifluoromethylbenzenesulfonyl)-10-methoxy-13-n-octylprotoberberine chloride
    参考文献:
    名称:
    Synthesis, structure–activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives
    摘要:
    Twenty-eight new 13-n-octylberberine derivatives were synthesized and evaluated for their activities against drug-susceptible Mycobacterium tuberculosis (M. tuberculosis) strain H(37)Rv. Among these compounds, compound 16e was the most effective anti-tubercular agent with a MIC value of 0.125 mu g/mL Importantly, compound 16e exhibited more potent effect against rifampicin (RIF)- and isoniazid (INH)-resistant M. tuberculosis strains than both RIF and INN, suggesting a new mechanism of action. Therefore, it has been selected as a drug candidate for further investigation, or as a chemical probe for identifying protein target and studying tuberculosis biology. We consider 13-n-octylberberine analogs to be a promising novel class of antituberculars against multi-drug-resistant (MDR) strains of M. tuberculosis. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.03.012
点击查看最新优质反应信息

文献信息

  • Synthesis, structure–activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives
    作者:Yan-Xin Liu、Chun-Ling Xiao、Yan-Xiang Wang、Ying-Hong Li、Yan-Hui Yang、Yang-Biao Li、Chong-Wen Bi、Li-Mei Gao、Jian-Dong Jiang、Dan-Qing Song
    DOI:10.1016/j.ejmech.2012.03.012
    日期:2012.6
    Twenty-eight new 13-n-octylberberine derivatives were synthesized and evaluated for their activities against drug-susceptible Mycobacterium tuberculosis (M. tuberculosis) strain H(37)Rv. Among these compounds, compound 16e was the most effective anti-tubercular agent with a MIC value of 0.125 mu g/mL Importantly, compound 16e exhibited more potent effect against rifampicin (RIF)- and isoniazid (INH)-resistant M. tuberculosis strains than both RIF and INN, suggesting a new mechanism of action. Therefore, it has been selected as a drug candidate for further investigation, or as a chemical probe for identifying protein target and studying tuberculosis biology. We consider 13-n-octylberberine analogs to be a promising novel class of antituberculars against multi-drug-resistant (MDR) strains of M. tuberculosis. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多